Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo. 1986

I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden

A series of nitroimidazoles containing aziridine and alkyl-substituted aziridine functions has been synthesized. The 2-nitroimidazole compounds examined all show greater radiosensitizing efficiency in vitro than misonidazole. The 4- and 5-nitroimidazole analogues are also more efficient than equivalent compounds which do not contain the alkylating aziridine moiety. All the compounds show increased toxicity towards hypoxic cells relative to aerobic cells, but this toxicity is reduced by alkyl-substitution of the aziridine ring. In vivo toxicity can also be reduced by modification of the aziridine function, but such alterations appear to have less effect upon the high radiosensitizing efficiency of these compounds in vivo. As a consequence of this study, compounds of potentially improved therapeutic utility compared to RSU-1069, the first reported member of this class, have been identified.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
July 1986, International journal of radiation oncology, biology, physics,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
January 1989, Cancer chemotherapy and pharmacology,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
June 1986, British journal of cancer,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
April 1989, International journal of radiation oncology, biology, physics,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
June 1987, Biochemical pharmacology,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
May 1984, British journal of cancer,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
December 1986, The British journal of radiology,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
August 1984, International journal of radiation oncology, biology, physics,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
September 1987, International journal of radiation oncology, biology, physics,
I Ahmed, and T C Jenkins, and J M Walling, and I J Stratford, and P W Sheldon, and G E Adams, and E M Fielden
January 1993, Drug design and discovery,
Copied contents to your clipboard!